COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 2413: Articles 24121-24130  | Next

IgG antibody seroconversion and the clinical progression of COVID-19 pneumonia: A retrospective, cohort study
Kurashima, K., Kagiyama, N., Ishiguro, T., Takaku, Y., Nakajima, H., Shibata, S., Matsui, Y., Takano, K., Isono, T., Nishida, T., Kawate, E., Hosoda, C., Kobayashi, Y., Takayanagi, N., Yanagisawa, T.
10.1101/2020.07.16.20154088 — Posted: 2020-07-17
ABO polymorphism and SARS-CoV-2 infection - a meta-analysis
Golinelli, D., Boetto, E., Maietti, E., Fantini, M. P.
10.1101/2020.07.17.20155986 — Posted: 2020-07-17
Continuity of services for patients with tuberculosis in China in the COVID-19 era
Shen, X., Sha, W., Yang, C., Pan, Q., Cohen, T., Chen, S., Cai, Q., Kan, X., Zong, P., Zeng, Z., Tan, S., Liang, R., Bai, L., Xia, J., Wu, S., Sun, P., Wu, G., Cai, C., Wang, X., Ai, K., Liu, J., Yuan, Z.
10.1101/2020.07.16.20150292 — Posted: 2020-07-17 Discussion: Offsite
Tele- Yoga therapy for Patients with Chronic Pain during Covid-19 Lockdown: A Prospective Nonrandomized Single Arm Clinical Trial
Sharma, N., Modi, D., Nathwani, A., Pandya, B., Joshi, J.
10.1101/2020.07.16.20154229 — Posted: 2020-07-17 Discussion: Onsite | Offsite
The global impact of the first Coronavirus Disease 2019 (COVID-19) pandemic wave on vascular services
Vascular and Endovascular Research Network, , Benson, R. A., Nandhra, S.
10.1101/2020.07.16.20153593 — Posted: 2020-07-17
Mapping physical access to healthcare for older adults in sub-Saharan Africa: A cross-sectional analysis with implications for the COVID-19 response
Reinmuth, M., Geldsetzer, P., Ouma, P. O., Lautenbach, S., Okiro, E. A., Baernighausen, T., Zipf, A.
10.1101/2020.07.17.20152389 — Posted: 2020-07-17
Preparedness, Perceived Impact and Concerns of health Care Workers in a Teaching Hospital during Coronavirus Disease 2019 (COVID-19)
Saurabh, K., Ranjan, S.
10.1101/2020.07.15.20140095 — Posted: 2020-07-17
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months
Wajnberg, A., Amanat, F., Firpo, A., Altman, D., Bailey, M., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., Stadlbauer, D., Stone, K., Strohmeier, S., Aberg, J., Reich, D., Krammer, F., Cordon-Cardo, C.
10.1101/2020.07.14.20151126 — Posted: 2020-07-17 Discussion: Onsite | Offsite
Reconciling model predictions with low reported cases of COVID-19 in Sub-Saharan Africa: Insights from Madagascar
Evans, M. V., Garchitorena, A. V., Rakotonanahary, R. J., Drake, J. M., Rajaonarifara, E., Ngonghala, C. N., ROCHE, B., Bonds, M. H., Rakotonirina, J.
10.1101/2020.07.15.20149195 — Posted: 2020-07-17
Qualitative Changes in the SARS-CoV-2 Antibody Response in the Post-Infection Phase Impact the estimates of infections in Population-Based Seroprevalence Studies
Fenwick, C., Croxatto, A., Coste, A. T., Pojer, F., Andre, C., Pellaton, C., Farina, A., Campos, J., Hacker, D., Lau, K., Bosch, B. J., Gonseth Nussle, S., Bochud, M., D'Acremont Genton, V., Trono, D., Greub, G., Pantaleo, G.
10.1101/2020.07.14.20153536 — Posted: 2020-07-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).